Funding
The development of ELIMU-MDx was funded by the public–private partnership, the Equatorial Guinea Malaria Vaccine Initiative (EGMVI), supported by the Government of Equatorial Guinea – Ministry of Mines and Energy and Ministry of Health and Social Welfare, Marathon EG Production Limited, Noble Energy and Atlantic Methanol Production Company. The authors declare no competing interests. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
